{
  "DOI": "10.1007/s12687-016-0274-4",
  "ISSN": [
    "1868-310X",
    "1868-6001"
  ],
  "URL": "http://dx.doi.org/10.1007/s12687-016-0274-4",
  "alternative-id": [
    "274"
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0002-7429-6970",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Soofi",
      "given": "Hojjat",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "van Leeuwen",
      "given": "Evert",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Journal of Community Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2016,
        8,
        5
      ]
    ],
    "date-time": "2016-08-05T07:37:24Z",
    "timestamp": 1470382644000
  },
  "deposited": {
    "date-parts": [
      [
        2017,
        6,
        24
      ]
    ],
    "date-time": "2017-06-24T20:01:40Z",
    "timestamp": 1498334500000
  },
  "indexed": {
    "date-parts": [
      [
        2022,
        4,
        2
      ]
    ],
    "date-time": "2022-04-02T17:58:53Z",
    "timestamp": 1648922333042
  },
  "is-referenced-by-count": 1,
  "issn-type": [
    {
      "type": "print",
      "value": "1868-310X"
    },
    {
      "type": "electronic",
      "value": "1868-6001"
    }
  ],
  "issue": "4",
  "issued": {
    "date-parts": [
      [
        2016,
        8,
        5
      ]
    ]
  },
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2016,
          10
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "unspecified",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2016,
            8,
            5
          ]
        ],
        "date-time": "2016-08-05T00:00:00Z",
        "timestamp": 1470355200000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s12687-016-0274-4.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s12687-016-0274-4/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s12687-016-0274-4",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s12687-016-0274-4.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "261-270",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2016,
        8,
        5
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2016,
        8,
        5
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2016,
        10
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.5455/2319-2003.ijbcp002912",
      "author": "S Aditya",
      "doi-asserted-by": "crossref",
      "first-page": "225",
      "journal-title": "Int J Basic Clin Pharmacol",
      "key": "274_CR1",
      "unstructured": "Aditya S (2012) Ivacaftor in cystic fibrosis: the first disease modifying agent. Int J Basic Clin Pharmacol 1:225–229",
      "volume": "1",
      "year": "2012"
    },
    {
      "DOI": "10.1126/scitranslmed.aac6023",
      "author": "M Anderson",
      "doi-asserted-by": "crossref",
      "first-page": "291fs225",
      "journal-title": "Sci Transl Med",
      "key": "274_CR2",
      "unstructured": "Anderson M, McCleary KK (2015) From passengers to co-pilots: patient roles expand. Sci Transl Med 7:291fs225–291fs225",
      "volume": "7",
      "year": "2015"
    },
    {
      "DOI": "10.1038/sj.tpj.6500131",
      "author": "DC Anderson",
      "doi-asserted-by": "publisher",
      "first-page": "284",
      "journal-title": "Pharmacogenomics J",
      "key": "274_CR3",
      "unstructured": "Anderson DC et al (2002) Elements of informed consent for pharmacogenetic research; perspective of the pharmacogenetics working group. Pharmacogenomics J 2:284–292. doi: 10.1038/sj.tpj.6500131",
      "volume": "2",
      "year": "2002"
    },
    {
      "DOI": "10.1001/jama.2013.58",
      "author": "H Bauchner",
      "doi-asserted-by": "crossref",
      "first-page": "607",
      "journal-title": "JAMA",
      "key": "274_CR4",
      "unstructured": "Bauchner H, Fontanarosa PB (2013) Restoring confidence in the pharmaceutical industry. JAMA 309:607–609",
      "volume": "309",
      "year": "2013"
    },
    {
      "author": "C Bliss",
      "first-page": "192",
      "key": "274_CR5",
      "unstructured": "Bliss C (2015) Biomedicalization and the new science of race. In: Bell SE, Figert AE (eds) Reimagining (Bio) medicalization, pharmaceuticals and genetics: Old critiques and New engagements. Routledge, New York, p 192",
      "volume-title": "Reimagining (Bio) medicalization, pharmaceuticals and genetics: Old critiques and New engagements",
      "year": "2015"
    },
    {
      "DOI": "10.1215/03616878-2009-009",
      "author": "VL Bonham",
      "doi-asserted-by": "crossref",
      "first-page": "325",
      "journal-title": "J Health Polit Policy Law",
      "key": "274_CR6",
      "unstructured": "Bonham VL, Citrin T, Modell SM, Franklin TH, Bleicher EW, Fleck LM (2009) Community-based dialogue: engaging communities of color in the United States’ genetics policy conversation. J Health Polit Policy Law 34:325–359",
      "volume": "34",
      "year": "2009"
    },
    {
      "DOI": "10.1353/ken.2002.0001",
      "author": "A Buchanan",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "journal-title": "Kennedy Inst Ethics J",
      "key": "274_CR7",
      "unstructured": "Buchanan A, Califano A, Kahn J, McPherson E, Robertson J, Brody B (2002) Pharmacogenetics: ethical issues and policy options. Kennedy Inst Ethics J 12:1–15",
      "volume": "12",
      "year": "2002"
    },
    {
      "DOI": "10.1038/35066094",
      "author": "R Chadwick",
      "doi-asserted-by": "crossref",
      "first-page": "318",
      "journal-title": "Nat Rev Gent",
      "key": "274_CR8",
      "unstructured": "Chadwick R, Berg K (2001) Solidarity and equity: new ethical frameworks for genetic databases. Nat Rev Gent 2:318–321",
      "volume": "2",
      "year": "2001"
    },
    {
      "DOI": "10.1038/nm0315-209",
      "author": "S Chakradhar",
      "doi-asserted-by": "crossref",
      "first-page": "209",
      "journal-title": "Nat Med",
      "key": "274_CR9",
      "unstructured": "Chakradhar S (2015) Training on trials: patients taught the language of drug development. Nat Med 21:209–210",
      "volume": "21",
      "year": "2015"
    },
    {
      "DOI": "10.1164/rccm.201204-0785PP",
      "author": "JP Clancy",
      "doi-asserted-by": "crossref",
      "first-page": "593",
      "journal-title": "Am J Respir Crit Care Med",
      "key": "274_CR10",
      "unstructured": "Clancy JP, Jain M (2012) Personalized medicine in cystic fibrosis: dawning of a new era. Am J Respir Crit Care Med 186:593–597",
      "volume": "186",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.shpsc.2006.06.004",
      "author": "OP Corrigan",
      "doi-asserted-by": "publisher",
      "first-page": "550",
      "journal-title": "Stud Hist Philos Biol Biomed Sci",
      "key": "274_CR11",
      "unstructured": "Corrigan OP, Williams-Jones B (2006) Pharmacogenetics: the bioethical problem of DNA investment banking. Stud Hist Philos Biol Biomed Sci 37:550–565. doi: 10.1016/j.shpsc.2006.06.004",
      "volume": "37",
      "year": "2006"
    },
    {
      "DOI": "10.1097/QAI.0b013e31824acdfb",
      "author": "EM Delaney",
      "doi-asserted-by": "crossref",
      "first-page": "e78",
      "journal-title": "J Acq Immun Def Synd",
      "key": "274_CR12",
      "unstructured": "Delaney EM et al (2012) Community advisory boards in HIV research: current scientific status and future directions. J Acq Immun Def Synd 59:e78–e81",
      "volume": "59",
      "year": "2012"
    },
    {
      "DOI": "10.2105/AJPH.2004.058933",
      "author": "N Dickert",
      "doi-asserted-by": "crossref",
      "first-page": "1123",
      "journal-title": "Am J Public Health",
      "key": "274_CR13",
      "unstructured": "Dickert N, Sugarman J (2005) Ethical goals of community consultation in research. Am J Public Health 95:1123–1127",
      "volume": "95",
      "year": "2005"
    },
    {
      "DOI": "10.2217/pme.13.10",
      "author": "ES Dove",
      "doi-asserted-by": "crossref",
      "first-page": "213",
      "journal-title": "Per Med",
      "key": "274_CR14",
      "unstructured": "Dove ES, Özdemir V (2013) All the postgenomic world is a stage: the actors and narrators required for translating pharmacogenomics into public health. Per Med 10:213–216",
      "volume": "10",
      "year": "2013"
    },
    {
      "DOI": "10.1186/gm392",
      "author": "ES Dove",
      "doi-asserted-by": "crossref",
      "first-page": "91",
      "journal-title": "Genome Med",
      "key": "274_CR15",
      "unstructured": "Dove ES, Faraj SA, Kolker E, Ozdemir V (2012) Designing a post-genomics knowledge ecosystem to translate pharmacogehealth nomics into public action. Genome Med 4:91",
      "volume": "4",
      "year": "2012"
    },
    {
      "DOI": "10.1111/bcp.12319",
      "author": "F Ehmann",
      "doi-asserted-by": "crossref",
      "first-page": "612",
      "journal-title": "Br J Clin Pharmacol",
      "key": "274_CR16",
      "unstructured": "Ehmann F, Caneva L, Papaluca M (2014) European medicines agency initiatives and perspectives on pharmacogenomics. Br J Clin Pharmacol 77:612–617",
      "volume": "77",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.clinthera.2013.07.358",
      "author": "B Elger",
      "doi-asserted-by": "crossref",
      "first-page": "e116",
      "journal-title": "Clin Ther",
      "key": "274_CR17",
      "unstructured": "Elger B (2013) Ethics and privacy of biobanks. Clin Ther 35:e116",
      "volume": "35",
      "year": "2013"
    },
    {
      "DOI": "10.1097/FPC.0b013e3283629ce9",
      "author": "A Fohner",
      "doi-asserted-by": "crossref",
      "first-page": "403",
      "journal-title": "Pharmacogenet Genomics",
      "key": "274_CR18",
      "unstructured": "Fohner A et al (2013) Pharmacogenetics in American Indian populations: analysis of CYP2D6, CYP3A4, CYP3A5, and CYP2C9 in the confederated Salish and Kootenai tribes. Pharmacogenet Genomics 23:403",
      "volume": "23",
      "year": "2013"
    },
    {
      "DOI": "10.1111/bdi.12322",
      "author": "MA Frye",
      "doi-asserted-by": "publisher",
      "first-page": "598",
      "journal-title": "Bipolar Disord",
      "key": "274_CR19",
      "unstructured": "Frye MA et al (2015) National survey and community advisory board development for a bipolar disorder biobank. Bipolar Disord 17:598–605. doi: 10.1111/bdi.12322 , Epub 2015 Aug 20",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.1126/scitranslmed.3003471",
      "author": "KM Giacomini",
      "doi-asserted-by": "crossref",
      "first-page": "153ps118",
      "journal-title": "Sci Transl Med",
      "key": "274_CR20",
      "unstructured": "Giacomini KM, Yee SW, Ratain MJ, Weinshilboum RM, Kamatani N, Nakamura Y (2012) Pharmacogenomics and patient care: one size does not fit all. Sci Transl Med 4:153ps118–153ps118",
      "volume": "4",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.socscimed.2006.08.028",
      "author": "G Haddow",
      "doi-asserted-by": "crossref",
      "first-page": "272",
      "journal-title": "Soc Sci Med",
      "key": "274_CR21",
      "unstructured": "Haddow G, Laurie G, Cunningham-Burley S, Hunter KG (2007) Tackling community concerns about commercialisation and genetic research: a modest interdisciplinary proposal. Soc Sci Med 64:272–282",
      "volume": "64",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.socscimed.2015.01.023",
      "author": "S Hogarth",
      "doi-asserted-by": "crossref",
      "first-page": "255",
      "journal-title": "Soc Sci Med",
      "key": "274_CR22",
      "unstructured": "Hogarth S (2015) Neoliberal technocracy: explaining how and why the US food and drug administration has championed pharmacogenomics. Soc Sci Med 131:255–262",
      "volume": "131",
      "year": "2015"
    },
    {
      "DOI": "10.1080/15265160600685556",
      "author": "KFC Holloway",
      "doi-asserted-by": "crossref",
      "first-page": "7",
      "journal-title": "Am J Bioethics",
      "key": "274_CR23",
      "unstructured": "Holloway KFC (2006) Accidental communities: race, emergency medicine, and the problem of PolyHeme®. Am J Bioethics 6:7–17",
      "volume": "6",
      "year": "2006"
    },
    {
      "DOI": "10.1111/j.1471-8847.2006.00173.x",
      "author": "S Holm",
      "doi-asserted-by": "crossref",
      "first-page": "82",
      "journal-title": "Dev World Bioeth",
      "key": "274_CR24",
      "unstructured": "Holm S (2008) Pharmacogenetics, race and global injustice. Dev World Bioeth 8:82–88",
      "volume": "8",
      "year": "2008"
    },
    {
      "DOI": "10.1038/tpj.2011.11",
      "author": "HC Howard",
      "doi-asserted-by": "publisher",
      "first-page": "155",
      "journal-title": "Pharmacogenomics J",
      "key": "274_CR25",
      "unstructured": "Howard HC, Joly Y, Avard D, Laplante N, Phillips M, Tardif JC (2011) Informed consent in the context of pharmacogenomic research: ethical considerations. Pharmacogenomics J 11:155–161. doi: 10.1038/tpj.2011.11",
      "volume": "11",
      "year": "2011"
    },
    {
      "DOI": "10.1046/j.1365-2796.2001.00879.x",
      "author": "M Ingelman-Sundberg",
      "doi-asserted-by": "crossref",
      "first-page": "186",
      "journal-title": "J Intern Med",
      "key": "274_CR26",
      "unstructured": "Ingelman-Sundberg M (2001) Pharmacogenetics: an opportunity for a safer and more efficient pharmacotherapy. J Intern Med 250:186–200",
      "volume": "250",
      "year": "2001"
    },
    {
      "DOI": "10.1177/0306312708091928",
      "author": "J Kahn",
      "doi-asserted-by": "crossref",
      "first-page": "737",
      "journal-title": "Soc Stud Sci",
      "key": "274_CR27",
      "unstructured": "Kahn J (2008) Exploiting race in drug development BiDil’s interim model of pharmacogenomics. Soc Stud Sci 38:737–758",
      "volume": "38",
      "year": "2008"
    },
    {
      "DOI": "10.1007/s11606-014-2923-9",
      "author": "E Kramer-Golinkoff",
      "doi-asserted-by": "crossref",
      "first-page": "808",
      "journal-title": "J Gen Intern Med",
      "key": "274_CR28",
      "unstructured": "Kramer-Golinkoff E (2014) A lesson in participatory research for a rare mutation of cystic fibrosis. J Gen Intern Med 29:808",
      "volume": "29",
      "year": "2014"
    },
    {
      "DOI": "10.2105/ajph.2005.068676",
      "doi-asserted-by": "publisher",
      "key": "274_CR29",
      "unstructured": "Lee SSJ (2005) Racializing drug design: implications of pharmacogenomics for health disparities. In: Am J Public Health, vol 95. vol 12. pp 2133-2138. doi: 10.2105/ajph.2005.068676"
    },
    {
      "DOI": "10.1186/1746-5354-6-3-50",
      "author": "AA Lemke",
      "doi-asserted-by": "crossref",
      "first-page": "35",
      "journal-title": "Genomics Soc Policy",
      "key": "274_CR30",
      "unstructured": "Lemke AA, Wu JT, Waudby C, Pulley J, Somkin CP, Trinidad SB (2010) Community engagement in biobanking: experiences from the eMERGE network. Genomics Soc Policy 6:35–52",
      "volume": "6",
      "year": "2010"
    },
    {
      "DOI": "10.1017/CBO9780511814600",
      "author": "NC Manson",
      "doi-asserted-by": "crossref",
      "key": "274_CR31",
      "unstructured": "Manson NC, O’Neill O (2007) Rethinking informed consent in bioethics. Cambridge University Press, Cambridge",
      "volume-title": "Rethinking informed consent in bioethics",
      "year": "2007"
    },
    {
      "DOI": "10.1002/ajmg.a.32559",
      "author": "CA McCarty",
      "doi-asserted-by": "publisher",
      "first-page": "3026",
      "journal-title": "Am J Med Genet A",
      "key": "274_CR32",
      "unstructured": "McCarty CA, Chapman-Stone D, Derfus T, Giampietro PF, Fost N, Marshfield Clinic PCAG (2008) Community consultation and communication for a population-based DNA biobank: the Marshfield clinic personalized medicine research project. Am J Med Genet A 146A:3026–3033. doi: 10.1002/ajmg.a.32559",
      "volume": "146A",
      "year": "2008"
    },
    {
      "DOI": "10.1016/S0140-6736(00)03167-6",
      "author": "UA Meyer",
      "doi-asserted-by": "crossref",
      "first-page": "1667",
      "journal-title": "Lancet",
      "key": "274_CR33",
      "unstructured": "Meyer UA (2000) Pharmacogenetics and adverse drug reactions. Lancet 356:1667–1671",
      "volume": "356",
      "year": "2000"
    },
    {
      "DOI": "10.2105/AJPH.2013.301605",
      "author": "L Mikesell",
      "doi-asserted-by": "crossref",
      "first-page": "e7",
      "journal-title": "Am J Public Health",
      "key": "274_CR34",
      "unstructured": "Mikesell L, Bromley E, Khodyakov D (2013) Ethical community-engaged research: a literature review. Am J Public Health 103:e7–e14",
      "volume": "103",
      "year": "2013"
    },
    {
      "author": "SD Newman",
      "first-page": "A70",
      "journal-title": "Prev Chronic Dis",
      "key": "274_CR35",
      "unstructured": "Newman SD, Andrews JO, Magwood GS, Jenkins C, Cox MJ, Williamson DC (2011) Community advisory boards in community-based participatory research: a synthesis of best processes. Prev Chronic Dis 8:A70",
      "volume": "8",
      "year": "2011"
    },
    {
      "DOI": "10.1016/S1369-8486(01)00026-7",
      "author": "O O’Neill",
      "doi-asserted-by": "crossref",
      "first-page": "689",
      "issue": "4",
      "journal-title": "Stud Hist Phil Biol Biomed Sci",
      "key": "274_CR36",
      "unstructured": "O’Neill O (2001) Informed consent and genetic information. Stud Hist Phil Biol Biomed Sci 32(4):689–704",
      "volume": "32",
      "year": "2001"
    },
    {
      "DOI": "10.1016/j.jaci.2013.10.040",
      "author": "VE Ortega",
      "doi-asserted-by": "crossref",
      "first-page": "16",
      "journal-title": "J Allergy Clin Immunol",
      "key": "274_CR37",
      "unstructured": "Ortega VE, Meyers DA (2014) Pharmacogenetics: implications of race and ethnicity on defining genetic profiles for personalized medicine. J Allergy Clin Immunol 133:16–26",
      "volume": "133",
      "year": "2014"
    },
    {
      "DOI": "10.1111/j.1748-720X.2012.00718.x",
      "author": "LS Parker",
      "doi-asserted-by": "crossref",
      "first-page": "886",
      "journal-title": "JL Med \u0026 Ethics",
      "key": "274_CR38",
      "unstructured": "Parker LS, Satkoske VB (2012) Ethical dimensions of disparities in depression research and treatment in the pharmacogenomic era. JL Med \u0026 Ethics 40:886",
      "volume": "40",
      "year": "2012"
    },
    {
      "DOI": "10.1353/ken.0.0004",
      "author": "K Peterson-Iyer",
      "doi-asserted-by": "crossref",
      "first-page": "35",
      "journal-title": "Kennedy Inst Ethics J",
      "key": "274_CR39",
      "unstructured": "Peterson-Iyer K (2008) Pharmacogenomics, ethics, and public policy. Kennedy Inst Ethics J 18:35–56",
      "volume": "18",
      "year": "2008"
    },
    {
      "DOI": "10.1111/bioe.12073",
      "author": "SK Prucka",
      "doi-asserted-by": "publisher",
      "first-page": "82",
      "journal-title": "Bioethics",
      "key": "274_CR40",
      "unstructured": "Prucka SK et al (2014) An update to returning genetic research results to individuals: perspectives of the industry pharmacogenomics working group. Bioethics 29:82–90. doi: 10.1111/bioe.12073 , Epub 2014 Jan 29",
      "volume": "29",
      "year": "2014"
    },
    {
      "DOI": "10.2105/AJPH.94.6.918",
      "author": "SC Quinn",
      "doi-asserted-by": "crossref",
      "first-page": "918",
      "journal-title": "Am J Public Health",
      "key": "274_CR41",
      "unstructured": "Quinn SC (2004) Ethics in public health research: protecting human subjects: the role of community advisory boards. Am J Public Health 94:918–922",
      "volume": "94",
      "year": "2004"
    },
    {
      "DOI": "10.1080/17290376.2010.9724963",
      "author": "P Reddy",
      "doi-asserted-by": "crossref",
      "first-page": "2",
      "journal-title": "SAHARA J",
      "key": "274_CR42",
      "unstructured": "Reddy P, Buchanan D, Sifunda S, James S, Naidoo N (2011) The role of community advisory boards in health research: divergent views in the south African experience. SAHARA J 7:2–8",
      "volume": "7",
      "year": "2011"
    },
    {
      "DOI": "10.1186/1472-6939-14-34",
      "author": "D Rose",
      "doi-asserted-by": "publisher",
      "first-page": "34",
      "journal-title": "BMC Med Ethics",
      "key": "274_CR43",
      "unstructured": "Rose D, Russo J, Wykes T (2013) Taking part in a pharmacogenetic clinical trial: assessment of trial participants understanding of information disclosed during the informed consent process. BMC Med Ethics 14:34. doi: 10.1186/1472-6939-14-34",
      "volume": "14",
      "year": "2013"
    },
    {
      "DOI": "10.1111/j.1748-720X.2011.00552.x",
      "author": "BM Rusert",
      "doi-asserted-by": "publisher",
      "first-page": "79",
      "journal-title": "J Law Med Ethics",
      "key": "274_CR44",
      "unstructured": "Rusert BM, Royal CD (2011) Grassroots marketing in a global era: more lessons from BiDil. J Law Med Ethics 39:79–90. doi: 10.1111/j.1748-720X.2011.00552.x",
      "volume": "39",
      "year": "2011"
    },
    {
      "author": "P Sankar",
      "key": "274_CR45",
      "unstructured": "Sankar P, Kahn JD (2005) BiDil: race medicine or race marketing? Health affairs., October 11",
      "volume-title": "BiDil: race medicine or race marketing? Health affairs",
      "year": "2005"
    },
    {
      "author": "RV Santos",
      "first-page": "48",
      "journal-title": "Bio Societies",
      "key": "274_CR46",
      "unstructured": "Santos RV, da Silva GO, Gibbon S (2015) Pharmacogenomics, human genetic diversity and the incorporation and rejection of color/race in Brazil. Bio Societies 10:48–69",
      "volume": "10",
      "year": "2015"
    },
    {
      "DOI": "10.2105/AJPH.2010.194340",
      "author": "N Shore",
      "doi-asserted-by": "publisher",
      "first-page": "S359",
      "issue": "Suppl 1",
      "journal-title": "Am J Public Health",
      "key": "274_CR47",
      "unstructured": "Shore N et al (2011) Understanding community-based processes for research ethics review: a national study. Am J Public Health 101(Suppl 1):S359–364. doi: 10.2105/AJPH.2010.194340",
      "volume": "101",
      "year": "2011"
    },
    {
      "DOI": "10.1525/jer.2011.6.3.19",
      "author": "CM Simon",
      "doi-asserted-by": "publisher",
      "first-page": "19",
      "journal-title": "J Empir Res Hum Res Ethics",
      "key": "274_CR48",
      "unstructured": "Simon CM, Newbury E, heureux JL (2011) Protecting participants, promoting progress: public perspectives on community advisory boards (CABs) in biobanking. J Empir Res Hum Res Ethics 6:19–30. doi: 10.1525/jer.2011.6.3.19",
      "volume": "6",
      "year": "2011"
    },
    {
      "DOI": "10.1080/09581590500523319",
      "author": "J-A Skolbekken",
      "doi-asserted-by": "crossref",
      "first-page": "335",
      "journal-title": "Critical Public Health",
      "key": "274_CR49",
      "unstructured": "Skolbekken J-A, Ursin LØ, Solberg B, Christensen E, Ytterhus B (2005) Not worth the paper it’s written on? Informed consent and biobank research in a Norwegian context. Critical Public Health 15:335–347",
      "volume": "15",
      "year": "2005"
    },
    {
      "DOI": "10.1111/j.1467-8519.2004.00400.x",
      "author": "A Smart",
      "doi-asserted-by": "crossref",
      "first-page": "322",
      "journal-title": "Bioethics",
      "key": "274_CR50",
      "unstructured": "Smart A, Martin P, Parker M (2004) Tailored medicine: whom will it fit? The ethics of patient and disease stratification. Bioethics 18:322–342",
      "volume": "18",
      "year": "2004"
    },
    {
      "DOI": "10.2105/AJPH.91.12.1938",
      "doi-asserted-by": "crossref",
      "key": "274_CR51",
      "unstructured": "Strauss RP, Sengupta S, Quinn SC, Goeppinger J, Spaulding C, Kegeles SM, Millett G (2001) The role of community advisory boards: involving communities in the informed consent process. In: Am J Public Health, vol 91. vol 12. pp 1938-1943"
    },
    {
      "DOI": "10.1089/gtmb.2015.1563",
      "author": "SF Terry",
      "doi-asserted-by": "publisher",
      "first-page": "113",
      "journal-title": "Genet Test Mol Biomarkers",
      "key": "274_CR52",
      "unstructured": "Terry SF (2015) Obama’s precision medicine initiative. Genet Test Mol Biomarkers 19:113–114. doi: 10.1089/gtmb.2015.1563",
      "volume": "19",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nrg1991",
      "author": "SF Terry",
      "doi-asserted-by": "publisher",
      "first-page": "157",
      "journal-title": "Nat Rev Genet",
      "key": "274_CR53",
      "unstructured": "Terry SF, Terry PF, Rauen KA, Uitto J, Bercovitch LG (2007) Advocacy groups as research organizations: the PXE international example. Nat Rev Genet 8:157–164. doi: 10.1038/nrg1991",
      "volume": "8",
      "year": "2007"
    },
    {
      "DOI": "10.1038/sj.tpj.6500219",
      "author": "C Weijer",
      "doi-asserted-by": "publisher",
      "first-page": "9",
      "journal-title": "Pharmacogenomics J",
      "key": "274_CR54",
      "unstructured": "Weijer C, Miller PB (2004) Protecting communities in pharmacogenetic and pharmacogenomic research. Pharmacogenomics J 4:9–16. doi: 10.1038/sj.tpj.6500219",
      "volume": "4",
      "year": "2004"
    },
    {
      "DOI": "10.1080/14636770902901611",
      "author": "H Widdows",
      "doi-asserted-by": "crossref",
      "first-page": "173",
      "journal-title": "New Genet Soc",
      "key": "274_CR55",
      "unstructured": "Widdows H (2009) Between the individual and the community: the impact of genetics on ethical models. New Genet Soc 28:173–188",
      "volume": "28",
      "year": "2009"
    },
    {
      "DOI": "10.1111/jlme.12288",
      "author": "SM Wolf",
      "doi-asserted-by": "publisher",
      "first-page": "440",
      "journal-title": "J Law Med Ethics",
      "key": "274_CR56",
      "unstructured": "Wolf SM et al (2015) Returning a research participant’s genomic results to relatives: analysis and recommendations. J Law Med Ethics 43:440–463. doi: 10.1111/jlme.12288",
      "volume": "43",
      "year": "2015"
    },
    {
      "DOI": "10.2217/pgs.14.91",
      "author": "EL Woodahl",
      "doi-asserted-by": "crossref",
      "first-page": "1235",
      "journal-title": "Pharmacogenomics",
      "key": "274_CR57",
      "unstructured": "Woodahl EL, Lesko LJ, Hopkins S, Robinson RF, Thummel KE, Burke W (2014) Pharmacogenetic research in partnership with American Indian and Alaska Native communities. Pharmacogenomics 15:1235–1241",
      "volume": "15",
      "year": "2014"
    }
  ],
  "reference-count": 57,
  "references-count": 57,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s12687-016-0274-4"
    }
  },
  "score": 0,
  "short-container-title": [
    "J Community Genet"
  ],
  "source": "Crossref",
  "title": [
    "Within and beyond the communal turn to informed consent in industry-sponsored pharmacogenetics research: merits and challenges of community advisory boards"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "7"
}